Brief: Tianda Pharmaceuticals Sees Loss Attributable For Interim Period Increase To Not Less Than HK$27 Mln
22/08/2024 11:45
Aug 22 (Reuters) - Tianda Pharmaceuticals Ltd 0455.HK :
* SEES LOSS ATTRIBUTABLE FOR INTERIM PERIOD INCREASE TO NOT
LESS
THAN HK$27 MILLION
* EXPECTED RESULT DUE TO DECLINE IN DEMAND FOR GROUP'S
PEDIATRIC
DRUG, OTHERS
Further company coverage: 0455.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianda Pharmaceuticals
See all newsBrief: Tianda Pharmaceuticals Says Loss Attributable Expected To Increase To Hk$61 Million For FY
Brief: Tianda Pharmaceuticals Clarifies On Fraudulent Fund Raising Scams
Brief: Tianda Pharmaceuticals Sees Loss Attributable For Interim Period Increase To Not Less Than HK$27 Mln
Brief: Tianda Pharmaceuticals Says Unit Granted Drug Registration Approval Of Ibuprofen Suspension By NMPA
Brief: Tianda Pharmaceuticals Says Drug Registration Approval Of "Nicorandil For Injection" By NMPA